MVP vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

MVP PAR
Technical
37
53
Catalyst
54
51
Sentiment
50
50
Fundamental
95
60
Momentum
49
42
Risk Gate
50
50

Key Metrics

MVP Metric PAR
$45.6MMarket Cap$99.4M
136KAvg Volume (20d)2.2M
N/AShort InterestN/A
$0.76552-Week High$0.470
$0.36552-Week Low$0.135
+0.0%Daily Change-7.4%
$0.405Reference Price$0.162
-0.8%ROE-180.2%
-1.1%Profit MarginN/A

Active Signals

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Drifting lower — down 4.7% over the last 5 days
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (11766.1x)
●Strong revenue growth (+51%)

Ask Scout AI to compare MVP and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

MVP vs PIQ →MVP vs SPL →MYX vs NSB →MYX vs NTI →MYX vs OCC →
MVP Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).